Dr. Furst is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5230 Pacific Concourse Dr
Ste 100
Los Angeles, CA 90045Phone+1 310-297-9221Fax+1 310-297-9222- Is this information wrong?
Education & Training
University of California (San Francisco)Fellowship, Rheumatology, 1975 - 1977
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1973 - 1975
Johns Hopkins UniversityResidency, Internal Medicine, 1968 - 1970- Johns Hopkins University School of MedicineClass of 1968
Certifications & Licensure
CA State Medical License 2002 - 2025
WA State Medical License 1992 - 2024
NJ State Medical License 1987 - 1993
IA State Medical License 1982 - 1992- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With Scleroderma Start of enrollment: 2003 Oct 01
- Scleroderma: Cyclophosphamide or Transplantation Start of enrollment: 2005 Jun 01
- Long-term Observation of Patients With Early Rheumatoid Arthritis Start of enrollment: 1993 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Evaluating the efficacy of biologics with and without methotrexate in the treatment of psoriatic arthritis: a network meta-analysis.Philip J Mease, Soumya Reddy, Sarah Ross, Jeffrey R Lisse, Paulo Reis, Kirstin Griffing, Christophe Sapin, Aisha Vadhariya, Daniel E Furst> ;RMD Open. 2024 Jan 31
- Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years.Choy, E., Vencovský, J., Wilson, A., Burmester, G., Coombs, D., Penn, S., Khan, N., Yee, J., Rahawi, K., McInnes, I., Charles-Schoeman, C., Giles, J., Lane, N., Furst, D.> ;Rheumatology and Therapy. 2024 Feb 1
- Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working Group.Dorthe B Berthelsen, Lee S Simon, John P A Ioannidis, Marieke Voshaar, Pam Richards, Niti Goel, Vibeke Strand, Sabrina M Nielsen, Beverly J Shea, Peter Tugwell, Susan ...> ;Seminars in Arthritis and Rheumatism. 2023 Dec 1
- Join now to see all
Journal Articles
- Long‐Term Safety of Rituximab in Rheumatoid Arthritis: Analysis from the SUNSTONE RegistryKenneth Saag, Daniel E Furst, Kevin L Winthrop, Arthritis Care & Research
- The Scleroderma Patient-Centered Intervention Network Cohort: Baseline Clinical Features and Comparison with Other Large Scleroderma CohortsDaniel E Furst, Robert Spiera, Maureen D Mayes, Lorinda Chung, Suzanne Kafaja, Virginia Steen, Shervin Assassi, Monique Hinchcliff, Rheumatology
- Safety and Efficacy of Subcutaneous Tocilizumab in Systemic Sclerosis: Results from the Open-Label Period of a Phase II Randomised Controlled Trial (faSScinate)Dinesh Khanna, Daniel Eric Furst, Emergency Medicine Journal
- Join now to see all
Lectures
- Clinical Triad: Rheumatology: Early Diagnoses You Don't Want to Miss2019 ACP Internal Medicine Meeting, Philadelphia - 4/11/2019
- High-Frequency Ultrasound of the Skin in Systemic Sclerosis: An Exploratory Study to Examine Correlation with Disease Activity and to Define the Minimally Detectable D...Global Academy for Medical Education (Elsevier), Las Vegas, Nevada - 9/20/2013
- Practical Suggestions on Intravenous Iloprost in Raynaud's Phenomenon and Digital Ulcer Secondary to Systemic Sclerosis: Systematic Literature Review and Expert ConsensusGlobal Academy for Medical Education (Elsevier), Newport Beach, California - 9/28/2012
- Join now to see all
Other
- High-Frequency Ultrasound of the Skin in Systemic Sclerosis: An Exploratory Study to Examine Correlation with Disease Activity and to Define the Minimally Detectable D...Daniel Furst, MD, BioMed Central
https://www.doximity.com/articles/596b1106-d25d-43ba-b6f6-cb36588ec95a
UpToDate, Wolters Kluwer Health - 2012-04-18 - High-Frequency Ultrasound of the Skin in Systemic Sclerosis: An Exploratory Study to Examine Correlation with Disease Activity and to Define the Minimally Detectable D...Daniel Furst, MD, BioMed Central
https://www.doximity.com/articles/596b1106-d25d-43ba-b6f6-cb36588ec95a
UpToDate, Wolters Kluwer Health - 2012-12-04 - Practical Suggestions on Intravenous Iloprost in Raynaud's Phenomenon and Digital Ulcer Secondary to Systemic Sclerosis: Systematic Literature Review and Expert ConsensusDaniel Furst, MD, Seminars in Arthritis & Rheumatism
https://www.doximity.com/articles/77f3eb9e-97ba-4506-a089-c6dab8de75b7
UpToDate, Wolters Kluwer Health - 2012-04-18 - Join now to see all
Press Mentions
AYUSH Ministry to Conduct World's First Multicentre Phase 3 Clinical Trial in Ayurveda for Rheumatoid ArthritisMarch 23rd, 2022- Philip J. Clements, MD, MPH, MACR, Is Recognized by Continental Who's WhoAugust 20th, 2020
Vascular Biomarkers Predict Pulmonary Hypertension in Systemic SclerosisApril 3rd, 2020- Join now to see all
Grant Support
- Provisional Combined Response Index For Patients With Diffuse Systemic SclerosisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2007–2009
- Oral Cyclophosphamide VS Oral Placebo In SSC AlveolitisNational Heart, Lung, And Blood Institute2001
- Analysis Of Controlled Trial Of Chlorambucil Vs. PlaceboFood And Drug Administration1985–1986
- Sodium Retaining Characteristics Of Carprofen And Indomethacin In ManNational Center For Research Resources1985
- Salicylsalicylic Acid--Rheumatoid ArthritisNational Center For Research Resources1985
Professional Memberships
- Member
- Master Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
